Breaking News

Smoking impairs immune response, even after quitting, study finds

February 14, 2024
YASSER AL-ZAYYAT/AFP via Getty Images

Smoking impairs immune response, even after quitting, new study says

New evidence shows that the impacts of smoking on the body are even more profound and longer-lasting than researchers had realized.

By Elizabeth Cooney


STAT+ | Biotech launches with $135 million for Vertex-competing pain medicine

Latigo Biotherapeutics launched Wednesday with $135 million and plans to compete with Vertex Pharmaceuticals.

By Allison DeAngelis


STAT+ | Digital tools helped lower blood pressure in marginalized patient groups

A new analysis suggests there ought to be more investment in novel hypertension programs for patients experiencing health disparities.

By Mario Aguilar



Adobe

Opinion: The health care system is ignoring world's most promising approach to preventing cardiovascular disease

The "next breakthrough" to fight hypertension already exists. It's called the polypill. Why isn't the U.S. health care system embracing it?

By Arthur L. Kellermann


STAT+ | FTC to probe the role of middlemen in worsening drug shortage crisis

The FTC wants to know whether group purchasing organizations and wholesalers are misusing their market power.

By Ed Silverman and John Wilkerson


STAT+ | Opinion: A year in, the U.S. is still not taking advantage of lower-cost biosimilars for Humira

Medicare beneficiaries and taxpayers could have saved close to $3 billion if more patients were getting Humira biosimilars.

By Juliana M. Reed


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments